Drugs / IPN59011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04736745 | Feb 2021 → Oct 2022 | — | Ipsen | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPN59011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04736745 ↗ |
| Route | Other | “injected locally” NCT04736745 ↗ |